Neoral absorption profiling: an evolution in effectiveness
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (3) , S45-S52
- https://doi.org/10.1016/s0041-1345(00)00863-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- CD40L (CD154) expression in human liver allografts during chronic ductopenic rejectionLiver Transplantation and Surgery, 1999
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- High variability of drug exposure: a biopharmaceutic risk factor for chronic rejectionTransplantation Proceedings, 1998
- Trough cyclosporine concentration variabilityTransplantation Proceedings, 1998
- Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantationTransplantation Proceedings, 1998
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1996
- REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2Transplantation, 1995
- Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from a Microemulsion FormulationJournal of Pharmaceutical Sciences, 1994
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993